Clinical and Urgent Colonoscopy Outcomes Using the Pure-Vu® Cleansing System

NCT04729946 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2023-06-23

No results posted yet for this study

Summary

The Pure-Vu® System can be effectively used as a cleansing device in patients admitted with acute LGIB to the intensive care unit and the regular nurse floor (RNF) bypassing the need to administer an oral bowel preparation for adequate visualization and hence decreasing time to colonoscopy and improving diagnostic and therapeutic yield.

Conditions

  • Lower Gastrointestinal Bleeding
  • Hemostatic Disorder

Interventions

DEVICE

Pure-Vu Cleansing Device

The Pure-Vu device attaches to the colonoscope and provides colonic cleansing during urgent colonoscopy without the need for a bowel preparation

Sponsors & Collaborators

  • Motus GI Medical Technologies Ltd

    collaborator INDUSTRY
  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Brian Baggott, MD · The Cleveland Clinic

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-03
Primary Completion
2022-04-06
Completion
2022-04-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04729946 on ClinicalTrials.gov